These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30128733)

  • 21. Treatment of schizophrenia with catatonic symptoms: A narrative review.
    Caroff SN; Ungvari GS; Gazdag G
    Schizophr Res; 2024 Jan; 263():265-274. PubMed ID: 36404216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant catatonia-induced respiratory failure with response to ECT.
    Boyarsky BK; Fuller M; Early T
    J ECT; 1999 Sep; 15(3):232-6. PubMed ID: 10492863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.
    Barnett BS; Balaji D; Weleff J; Carroll BT
    J Acad Consult Liaison Psychiatry; 2023; 64(3):277-293. PubMed ID: 36586471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute catatonia].
    Karl S; Schönfeldt-Lecuona C; Hirjak D; Sartorius A
    Nervenarzt; 2023 Feb; 94(2):106-112. PubMed ID: 36416934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum iron in catatonia and neuroleptic malignant syndrome.
    Lee JW
    Biol Psychiatry; 1998 Sep; 44(6):499-507. PubMed ID: 9777183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive therapy in the intensive care unit for the treatment of catatonia: a case series and review of the literature.
    Dessens FM; van Paassen J; van Westerloo DJ; van der Wee NJ; van Vliet IM; van Noorden MS
    Gen Hosp Psychiatry; 2016; 38():37-41. PubMed ID: 26589764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catatonic features: differential diagnosis and treatments at an emergency unit.
    Huang TL; Ree SC; Huang YC; Liu HY; Yang YY
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):63-6. PubMed ID: 10201286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F; Lattanzi L; Perlis RH; Litta A; Fui E; Bonuccelli U; Fricchione G; Cassano GB
    Psychosomatics; 2010; 51(4):349-54. PubMed ID: 20587766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D; Dell'Atti M; Amore M; De Ronchi D; Ferrari G
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catatonia and neuroleptic malignant syndrome: two sides of a coin?
    Vancaester E; Santens P
    Acta Neurol Belg; 2007 Jun; 107(2):47-50. PubMed ID: 17710840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lethal catatonia responding to high-dose olanzapine therapy.
    Cassidy EM; O'Brien M; Osman MF; Finucane J; O'Keane V
    J Psychopharmacol; 2001 Dec; 15(4):302-4. PubMed ID: 11769826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome.
    Kuhlwilm L; Schönfeldt-Lecuona C; Gahr M; Connemann BJ; Keller F; Sartorius A
    Acta Psychiatr Scand; 2020 Sep; 142(3):233-241. PubMed ID: 32659853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lethal catatonia and neuroleptic malignant syndrome. A dopamine receptor shut-down hypothesis.
    Osman AA; Khurasani MH
    Br J Psychiatry; 1994 Oct; 165(4):548-50. PubMed ID: 7804674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.